Daratumumab Shows Promise for High-Risk Smoldering Multiple Myeloma
New NEJM study compares early treatment with daratumumab versus watchful waiting for high-risk smoldering multiple myeloma patients.
Latest breakthroughs in cancer research, treatment, and prevention
656 articles
New NEJM study compares early treatment with daratumumab versus watchful waiting for high-risk smoldering multiple myeloma patients.
New review reveals how neurotransmitters like norepinephrine and acetylcholine directly regulate immune cells in tumors, opening therapeutic targets.
New review reveals how targeting mitochondria in cancer cells could overcome immunotherapy resistance and enhance anti-tumor responses.
Novel treatment triggers ferroptosis in cancer cells while activating immune responses that further enhance cancer cell death.
New research reveals how tumors release metabolites that prepare the brain's protective layers for cancer invasion.
New research reveals how metastatic cancer cells breach brain defenses through extracellular vesicle communication.
New review reveals how advanced genomics tools are revolutionizing cancer diagnosis and therapy development.
Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.
Researchers develop CAR-T cell therapy specifically targeting KRAS mutations, offering new hope for treating previously difficult cancers.
Harvard researcher calls for urgent action linking cancer, climate change, and fossil fuel pollution in groundbreaking analysis.
Leading oncologists address current controversies in breast cancer screening guidelines and practices.
New review reveals how senescent cells both prevent and promote cancer, opening therapeutic opportunities.